LYRA
Lyra Therapeutics·NASDAQ
--
--(--)
--
--(--)
LYRA Filings
Filing Date
Form Description
Form Type
2026-02-06
Form 8-K - Current report
Key Events
2026-02-06 · Key Events
Form 8-K - Current report
2026-01-27
Form 144 - Report of proposed sale of securities
Ownership
2026-01-27 · Ownership
Form 144 - Report of proposed sale of securities
2026-01-20
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026-01-20 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026-01-12
Form 8-K - Current report
Key Events
2026-01-12 · Key Events
Form 8-K - Current report
2026-01-08
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-01-08 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-01-08
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-01-08 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-01-06
Form 144 - Report of proposed sale of securities
Ownership
2026-01-06 · Ownership
Form 144 - Report of proposed sale of securities
2025-11-25
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2025-11-25 ·
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2025-11-18
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2025-11-18 ·
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2025-11-13
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2025-11-13 ·
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
